Tayama S, Okumura K, Matsunaga T, Tsunoda R, Tabuchi T, Iwasa A, Yasue H
Division of Cardiology, Kumamoto University School of Medicine, Honjo, Japan.
Jpn Circ J. 1998 May;62(5):371-8. doi: 10.1253/jcj.62.371.
The effect of chronic inhibition of endothelium-derived nitric oxide (NO) synthesis on the regulation of coronary blood flow (CBF) is yet to be elucidated. A chronic canine model of inhibited NO synthesis was created and the role of adenosine in the regulation of coronary blood flow in this model was examined. Dogs were fed a diet supplemented with 40 mg/kg per day N(G)-nitro-L-arginine methyl ester (L-NAME group, n=8) or a regular diet without L-NAME supplementation (control group, n=8) for 4 weeks. The experiments were performed in an anesthetized, open-chest state and the results were compared in the L-NAME and control groups. Chronic L-NAME treatment significantly increased arterial pressure. Neither basal CBF in the left anterior descending artery nor heart rate differed between the L-NAME and control groups. In the L-NAME group, the response of CBF to intracoronary acetylcholine and adenosine was blunted, but that to glyceryl trinitrate was not. In addition, myocardial reactive hyperemia following 20 sec coronary occlusion was blunted in the L-NAME group. During atrial pacing at a rate 60 beats/min faster than the sinus rate, CBF increased to a similar degree in the L-NAME and control groups, and systolic wall thickening (SWT) changed similarly in both groups. Intracoronary 8-phenyltheophylline (8-PT), an adenosine receptor blocker, decreased basal CBF in the L-NAME group but not in the control group. In the L-NAME group, pacing-induced increase in CBF was abolished and SWT deteriorated after 8-PT administration. Basal myocardial adenosine release was significantly increased in the L-NAME group compared with the control group. It is concluded that in anesthetized, open-chest dogs with chronic inhibition of NO synthesis, adenosine may play a compensatory role in the regulation of coronary blood flow, as concomitant blockade of adenosine causes deterioration of coronary circulation and cardiac function.
内皮源性一氧化氮(NO)合成的长期抑制对冠状动脉血流(CBF)调节的影响尚待阐明。建立了一个长期抑制NO合成的犬类模型,并研究了腺苷在该模型中对冠状动脉血流调节的作用。给犬喂食每天补充40mg/kg N(G)-硝基-L-精氨酸甲酯的饮食(L-NAME组,n = 8)或不补充L-NAME的常规饮食(对照组,n = 8),持续4周。实验在麻醉、开胸状态下进行,并在L-NAME组和对照组之间比较结果。长期L-NAME治疗显著增加动脉血压。L-NAME组和对照组之间左前降支动脉的基础CBF和心率均无差异。在L-NAME组中,CBF对冠状动脉内乙酰胆碱和腺苷的反应减弱,但对硝酸甘油的反应未减弱。此外,L-NAME组在冠状动脉闭塞20秒后的心肌反应性充血减弱。在心房起搏频率比窦性心率快60次/分钟时,L-NAME组和对照组的CBF增加程度相似,两组的收缩期壁增厚(SWT)变化也相似。冠状动脉内给予腺苷受体阻滞剂8-苯基茶碱(8-PT)可降低L-NAME组的基础CBF,但对照组未降低。在L-NAME组中,8-PT给药后起搏诱导的CBF增加被消除,SWT恶化。与对照组相比,L-NAME组的基础心肌腺苷释放显著增加。结论是,在麻醉、开胸且长期抑制NO合成的犬中,腺苷可能在冠状动脉血流调节中起代偿作用,因为同时阻断腺苷会导致冠状动脉循环和心脏功能恶化。